Cancer is the leading cause of death in older dogs, responsible for nearly half of all deaths in dogs over age 10. There isn’t one single cause. Like human cancer, canine cancer develops from a combination of genetic predisposition, environmental exposures, hormonal changes, and the biological reality of aging. Understanding these factors can help you reduce your dog’s risk where possible and catch problems early.
Genetics and Breed Predisposition
Certain breeds carry inherited genetic mutations that make them significantly more likely to develop specific cancers. These aren’t random misfortunes. They’re predictable patterns tied to well-identified genes.
Golden Retrievers are predisposed to lymphoma, a cancer of the immune system. Researchers have identified a deletion on chromosome 14 that appears exclusively in one form of the disease and occurs in Golden Retrievers at higher rates than in other breeds. Spaying or neutering a female Golden Retriever at any age increases cancer risk from about 5 percent to as high as 15 percent, according to research from UC Davis.
Bernese Mountain Dogs face an especially grim picture: a cancer called histiocytic sarcoma accounts for 25 percent of all cancer diagnoses in the breed. The tumors involve abnormalities in several genes that normally act as brakes on cell growth. Rottweilers, Great Danes, Dobermans, and Saint Bernards are prone to osteosarcoma (bone cancer), which is linked to mutations in the p53 gene, one of the body’s most important tumor-suppressing mechanisms. German Shepherds are predisposed to hemangiosarcoma, a cancer of the blood vessel walls, also tied to mutations in that same p53 pathway. Boxers and other flat-faced breeds have elevated rates of brain tumors.
The common thread across these breed-specific cancers is damage to tumor suppressor genes. In a healthy cell, these genes act like emergency brakes, stopping a cell from dividing out of control. When they’re mutated or missing, that safety mechanism fails.
How Aging Drives Cancer Risk
Age is the single strongest risk factor for cancer in dogs, just as it is in people. The reason comes down to what happens inside cells over a lifetime.
As dogs age, their cells accumulate damage from 12 overlapping biological processes: genomic instability, shortening of telomeres (the protective caps on chromosomes), shifts in how genes are turned on and off, and a breakdown in the systems that clear out damaged proteins. One process stands out as especially important. Cellular senescence, the state where cells stop dividing but don’t die, has emerged as a central contributor to age-related disease in dogs.
Senescent cells are essentially retired but still active. They sit in tissues and pump out a cocktail of inflammatory molecules, growth factors, and enzymes that researchers call the senescence-associated secretory phenotype, or SASP. These signals disrupt the healthy cells around them, creating chronic low-grade inflammation that damages tissue and weakens the body’s ability to catch and destroy abnormal cells. Over time, this creates an environment where cancer is far more likely to take hold. It’s why cancer rates climb steeply once dogs reach middle age and beyond.
Environmental Toxins and Chemical Exposure
Your dog’s environment plays a measurable role in cancer risk, and some of the most common exposures happen in your own yard.
Lawn herbicides are a well-studied concern. Exposure to chemically treated lawns has been associated with significantly higher bladder cancer risk in dogs. Researchers have also found a positive association between lawn chemical exposure and lymphoma, with the herbicide 2,4-D (one of the most widely used weed killers in residential products) specifically linked to increased risk. Dogs walk through treated grass, lie on it, and lick their paws, creating routes of exposure that don’t apply to humans in the same way. Studies have detected herbicides in the urine of pet dogs after home lawn applications, confirming that the chemicals are being absorbed.
Secondhand tobacco smoke is another documented risk. Dogs living with smokers face higher rates of nasal and lung cancers. The effect varies by anatomy: long-nosed breeds like Collies and Greyhounds have roughly double the risk of nasal cancer compared to short-nosed breeds, because the toxins in cigarette smoke accumulate along their longer nasal passages. Short-nosed breeds, meanwhile, may be more vulnerable to lung cancer because more of the smoke bypasses the nasal filter and reaches the lungs directly.
Ultraviolet Light and Skin Cancer
Sun exposure causes skin cancer in dogs the same way it does in people, through cumulative UV damage to skin cells. The dogs most at risk are those with white or light-colored coats and pink, non-pigmented skin. Cancers from UV exposure tend to develop in areas with thin or sparse fur: around the eyes, nose, ears, and on the belly.
Dogs that spend a lot of time outdoors and have light skin on their abdomen are particularly vulnerable to sun-related cancers in that area. If your dog is white-coated or has pink skin visible through thin fur, limiting midday sun exposure and providing shaded rest areas can reduce cumulative UV damage over their lifetime.
Obesity and Chronic Inflammation
Excess body fat doesn’t just strain your dog’s joints. It actively promotes cancer through a biological chain reaction. Fat tissue triggers an immune response that produces inflammatory molecules, including tumor necrosis factor (TNF) and several interleukins. These molecules generate reactive oxygen species, which are unstable molecules that damage DNA and other cell components.
This creates a state called oxidative stress, where the body can’t neutralize damaging molecules fast enough to prevent injury. The damaged cells release more inflammatory signals, which produce more reactive oxygen species, creating a self-reinforcing cycle. Over time, this chronic inflammation damages DNA in ways that can initiate or accelerate tumor growth. Veterinary research has directly linked obesity and its resulting oxidative stress to increased cancer risk in dogs. Keeping your dog at a healthy weight is one of the most concrete things you can do to lower their lifetime cancer risk.
Hormones and Spay/Neuter Timing
The relationship between spaying or neutering and cancer is more complicated than most pet owners realize. Reproductive hormones influence cancer risk in both directions, protecting against some cancers while promoting others.
A large UC Davis study that examined 35 breeds found that the cancer impact of neutering varies dramatically by breed, sex, and timing. In Golden Retrievers, spaying females at any age increased the risk of at least one cancer type from 5 percent to up to 15 percent. In smaller breeds like Boston Terriers and Shih Tzus, neutering was associated with a significant increase in cancer rates. The cancers most affected by neutering status include lymphoma, hemangiosarcoma, mast cell tumors, and osteosarcoma.
This doesn’t mean you should avoid spaying or neutering. The decision involves weighing cancer risk against other health concerns, including mammary tumors in intact females and the practical realities of pet ownership. But the research makes clear that the optimal timing depends on your dog’s breed and size, and that a one-size-fits-all approach doesn’t serve every dog equally.
Early Detection Through Blood Testing
One of the most promising developments in canine cancer care is liquid biopsy testing, a blood-based screening that can detect cancer-related genetic changes without surgery or imaging. These tests analyze fragments of DNA that tumors shed into the bloodstream, looking for mutations in genes like TP53 and KRAS that are commonly involved in cancer in both dogs and humans.
A proof-of-concept study published in Frontiers in Veterinary Science demonstrated that this type of blood test can detect multiple classes of cancer-associated genetic changes, including mutations from tumor sites in different parts of the body. The technology is designed to be used annually in high-risk breeds, catching cancer at earlier stages when treatment outcomes are better. While still relatively new in veterinary medicine, liquid biopsy represents a practical tool for owners of breeds with elevated cancer rates who want to be proactive about screening.